A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (R/RMM)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
A Phase I Study of SHR-3836 in Patients With Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
- Status
- RECRUITING
- Phase
- PHASE2
Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
- Status
- RECRUITING
- Phase
- N/A
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
- Status
- RECRUITING
- Phase
- N/A
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
- Status
- RECRUITING
- Phase
- NA